T2 Bio's T2SARS-CoV-2 Panel detects SARS-CoV-2 within two hours using a nasopharyngeal swab sample and runs on the firm's T2Dx instrument.

Labs are finding cheaper, higher-throughput ways to determine the inflection points in gene expression within a particular cell.

The Warsaw, Poland-based startup expects to submit a rapid SARS-CoV-2 molecular test for EUA and is seeking US manufacturing and distribution partners.

The European project will use single-cell profiling technologies to build well-characterized in vitro models of human organs and contribute to the Human Cell Atlas.

China increased the amount it spent on research and development by more than 10 percent in 2019, ScienceInsider says.

According to the New York Times, the US is launching a new program to monitor emerging diseases.

Researchers in the UK are building a database of dog DNA to uncover inherited disease among dog breeds with low numbers, Wired UK reports.

In PLOS this week: computational tool to uncover selection within populations, sequencing-based analysis of canine lymphoma, and more.

The grant, which was awarded under the NIH Pathway to Independence program, will fund research into the genetics of Alzheimer's disease.

Last week, GenomeWeb's readers were most interested in a court order to Illumina to make patent inventors available for depositions in an infringement lawsuit against BGI.

The goal of the project is to build a liquid biopsy-based early detection technology platform and develop tests for lung and digestive system cancers.

Axol Bioscience has appointed Liam Taylor as its CEO. Taylor most recently served as CFO and then managing director of BBI solutions.

The test is a version of Thermo Fisher Scientific's TaqPath COVID-19 Combo Kit that has been modified for use with a different PCR instrument and plate format.

The Harvard University spinout uses a combination of proprietary probes, nanoarrays, and convection PCR to target a broad set of molecular biomarkers.

Researchers used the methylCIBERSORT algorithm to determine the makeup of the tumor immune microenvironment of about 6,000 pediatric central nervous system tumors.

The company is using newly raised funds to support a disseminated trial model, which it said will help it keep its plans to finish the study by the end of 2021.

Wired reports that coronavirus pandemic and the ensuing lab shutdowns and policy changes are having an effect on the careers of young researchers.

The Economist writes that authorizations for some COVID-19 treatments and vaccines are ahead of the data.

The US National Institutes of Health is establishing the Centers for Research in Emerging Infectious Diseases to study pathogen spillover.

In Science this week: 29 widespread antiviral gene cassettes uncovered, and more.

News items for the week of August 24, 2020. 

The UK Coronavirus Immunology Consortium is one of three projects to receive a total of £8.4 million from UKRI and NIHR to study immune response to the novel coronavirus.

Cellink said that Ido Amit is joining the company's scientific advisory board. Amit is a researcher in the Immunology Department at the Weizmann Institute of Science in Israel, where he also earned his PhD in biological regulation. He was a postdoctoral fellow at the Broad Institute at Harvard University and the Massachusetts Institute of Technology. Amit's expertise is in the area of single-cell genomic technologies and their application to characterize the immune system, and as such he will guide Cellink's efforts to build a strong product portfolio for single-cell omics analysis, the company said.